Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.09
HSRPP's Cash to Debt is ranked lower than
74% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. HSRPP: 0.09 )
Ranked among companies with meaningful Cash to Debt only.
HSRPP' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.06 Max: N/A
Current: 0.09
Equity to Asset 0.14
HSRPP's Equity to Asset is ranked lower than
86% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 0.43 vs. HSRPP: 0.14 )
Ranked among companies with meaningful Equity to Asset only.
HSRPP' s 10-Year Equity to Asset Range
Min: -0.77  Med: 0.13 Max: 0.59
Current: 0.14
-0.77
0.59
Interest Coverage 4.28
HSRPP's Interest Coverage is ranked lower than
66% of the 122 Companies
in the Global Medical Care industry.

( Industry Median: 7.21 vs. HSRPP: 4.28 )
Ranked among companies with meaningful Interest Coverage only.
HSRPP' s 10-Year Interest Coverage Range
Min: 0.29  Med: 3.24 Max: 9999.99
Current: 4.28
0.29
9999.99
F-Score: 4
Z-Score: 1.40
M-Score: -2.54
WACC vs ROIC
9.45%
16.02%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 18.72
HSRPP's Operating margin (%) is ranked higher than
86% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.51 vs. HSRPP: 18.72 )
Ranked among companies with meaningful Operating margin (%) only.
HSRPP' s 10-Year Operating margin (%) Range
Min: -3.55  Med: 18.41 Max: 37.8
Current: 18.72
-3.55
37.8
Net-margin (%) 8.64
HSRPP's Net-margin (%) is ranked higher than
74% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 3.29 vs. HSRPP: 8.64 )
Ranked among companies with meaningful Net-margin (%) only.
HSRPP' s 10-Year Net-margin (%) Range
Min: -36.52  Med: 4.80 Max: 48.3
Current: 8.64
-36.52
48.3
ROE (%) 49.85
HSRPP's ROE (%) is ranked higher than
97% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 8.87 vs. HSRPP: 49.85 )
Ranked among companies with meaningful ROE (%) only.
HSRPP' s 10-Year ROE (%) Range
Min: -22.44  Med: 15.76 Max: 1312.58
Current: 49.85
-22.44
1312.58
ROA (%) 7.31
HSRPP's ROA (%) is ranked higher than
74% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 3.19 vs. HSRPP: 7.31 )
Ranked among companies with meaningful ROA (%) only.
HSRPP' s 10-Year ROA (%) Range
Min: -17.98  Med: 5.15 Max: 44.36
Current: 7.31
-17.98
44.36
ROC (Joel Greenblatt) (%) 40.13
HSRPP's ROC (Joel Greenblatt) (%) is ranked higher than
74% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 16.21 vs. HSRPP: 40.13 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HSRPP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -29.05  Med: 37.58 Max: 51.02
Current: 40.13
-29.05
51.02
Revenue Growth (3Y)(%) 8.70
HSRPP's Revenue Growth (3Y)(%) is ranked higher than
57% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. HSRPP: 8.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HSRPP' s 10-Year Revenue Growth (3Y)(%) Range
Min: -27  Med: -1.10 Max: 8.7
Current: 8.7
-27
8.7
EBITDA Growth (3Y)(%) 14.10
HSRPP's EBITDA Growth (3Y)(%) is ranked higher than
72% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. HSRPP: 14.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HSRPP' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -3.80 Max: 19.8
Current: 14.1
0
19.8
EPS Growth (3Y)(%) 16.40
HSRPP's EPS Growth (3Y)(%) is ranked higher than
62% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. HSRPP: 16.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HSRPP' s 10-Year EPS Growth (3Y)(%) Range
Min: -47.9  Med: 6.90 Max: 56
Current: 16.4
-47.9
56
» HSRPP's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HSRPP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Healthsouth Corp

SymbolPriceYieldDescription
HSRPP1557.374.206 1/2% Conv Perp Pfd Shs Series -A-
HLSHP0.000.00Conv Pfd Shs Series A -144A

Ratios

vs
industry
vs
history
P/E(ttm) 21.20
HSRPP's P/E(ttm) is ranked higher than
68% of the 139 Companies
in the Global Medical Care industry.

( Industry Median: 27.60 vs. HSRPP: 21.20 )
Ranked among companies with meaningful P/E(ttm) only.
HSRPP' s 10-Year P/E(ttm) Range
Min: 1.71  Med: 11.32 Max: 32.2
Current: 21.2
1.71
32.2
Forward P/E 17.95
HSRPP's Forward P/E is ranked higher than
64% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 19.65 vs. HSRPP: 17.95 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.70
HSRPP's PE(NRI) is ranked higher than
67% of the 138 Companies
in the Global Medical Care industry.

( Industry Median: 27.60 vs. HSRPP: 21.70 )
Ranked among companies with meaningful PE(NRI) only.
HSRPP' s 10-Year PE(NRI) Range
Min: 1.84  Med: 13.53 Max: 181.64
Current: 21.7
1.84
181.64
P/B 8.40
HSRPP's P/B is ranked lower than
92% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. HSRPP: 8.40 )
Ranked among companies with meaningful P/B only.
HSRPP' s 10-Year P/B Range
Min: 6.91  Med: 8.83 Max: 191.71
Current: 8.4
6.91
191.71
P/S 1.87
HSRPP's P/S is ranked lower than
58% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 1.52 vs. HSRPP: 1.87 )
Ranked among companies with meaningful P/S only.
HSRPP' s 10-Year P/S Range
Min: 0.4  Med: 1.15 Max: 3.95
Current: 1.87
0.4
3.95
PFCF 16.28
HSRPP's PFCF is ranked higher than
66% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 21.51 vs. HSRPP: 16.28 )
Ranked among companies with meaningful PFCF only.
HSRPP' s 10-Year PFCF Range
Min: 1.77  Med: 9.44 Max: 17.58
Current: 16.28
1.77
17.58
POCF 10.73
HSRPP's POCF is ranked higher than
71% of the 150 Companies
in the Global Medical Care industry.

( Industry Median: 15.38 vs. HSRPP: 10.73 )
Ranked among companies with meaningful POCF only.
HSRPP' s 10-Year POCF Range
Min: 1.53  Med: 6.36 Max: 10.87
Current: 10.73
1.53
10.87
EV-to-EBIT 13.13
HSRPP's EV-to-EBIT is ranked higher than
77% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 19.70 vs. HSRPP: 13.13 )
Ranked among companies with meaningful EV-to-EBIT only.
HSRPP' s 10-Year EV-to-EBIT Range
Min: -35.1  Med: 11.60 Max: 90.2
Current: 13.13
-35.1
90.2
PEG 1.44
HSRPP's PEG is ranked higher than
77% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 2.91 vs. HSRPP: 1.44 )
Ranked among companies with meaningful PEG only.
HSRPP' s 10-Year PEG Range
Min: 1.03  Med: 1.54 Max: 2.66
Current: 1.44
1.03
2.66
Shiller P/E 15.75
HSRPP's Shiller P/E is ranked higher than
86% of the 80 Companies
in the Global Medical Care industry.

( Industry Median: 28.84 vs. HSRPP: 15.75 )
Ranked among companies with meaningful Shiller P/E only.
HSRPP' s 10-Year Shiller P/E Range
Min: 5.2  Med: 10.70 Max: 41.57
Current: 15.75
5.2
41.57
Current Ratio 1.74
HSRPP's Current Ratio is ranked higher than
67% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. HSRPP: 1.74 )
Ranked among companies with meaningful Current Ratio only.
HSRPP' s 10-Year Current Ratio Range
Min: 0.6  Med: 1.85 Max: 6.95
Current: 1.74
0.6
6.95
Quick Ratio 1.74
HSRPP's Quick Ratio is ranked higher than
72% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. HSRPP: 1.74 )
Ranked among companies with meaningful Quick Ratio only.
HSRPP' s 10-Year Quick Ratio Range
Min: 0.6  Med: 1.85 Max: 6.95
Current: 1.74
0.6
6.95
Days Sales Outstanding 48.95
HSRPP's Days Sales Outstanding is ranked lower than
55% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 46.89 vs. HSRPP: 48.95 )
Ranked among companies with meaningful Days Sales Outstanding only.
HSRPP' s 10-Year Days Sales Outstanding Range
Min: 40.54  Med: 45.81 Max: 89.44
Current: 48.95
40.54
89.44

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 4.20
HSRPP's Dividend Yield is ranked higher than
51% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 1.71 vs. HSRPP: 4.20 )
Ranked among companies with meaningful Dividend Yield only.
HSRPP' s 10-Year Dividend Yield Range
Min: 0.5  Med: 1.77 Max: 2.09
Current: 4.2
0.5
2.09
Yield on cost (5-Year) 4.20
HSRPP's Yield on cost (5-Year) is ranked lower than
51% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HSRPP: 4.20 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HSRPP' s 10-Year Yield on cost (5-Year) Range
Min: 0.5  Med: 1.77 Max: 2.09
Current: 4.2
0.5
2.09
Share Buyback Rate 2.70
HSRPP's Share Buyback Rate is ranked higher than
89% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. HSRPP: 2.70 )
Ranked among companies with meaningful Share Buyback Rate only.
HSRPP' s 10-Year Share Buyback Rate Range
Min: 2.7  Med: -1.90 Max: -31.9
Current: 2.7

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) (%) 7.60
HSRPP's Earnings Yield (Greenblatt) (%) is ranked higher than
82% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. HSRPP: 7.60 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HSRPP' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.1  Med: 8.40 Max: 16.5
Current: 7.6
1.1
16.5
Forward Rate of Return (Yacktman) (%) 20.43
HSRPP's Forward Rate of Return (Yacktman) (%) is ranked higher than
76% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 10.88 vs. HSRPP: 20.43 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HSRPP' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 3.2  Med: 11.90 Max: 26.7
Current: 20.43
3.2
26.7

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Traded in other countries:HLS.USA, HSOA.Germany,
HealthSouth Corp was organized as a Delaware corporation in February 1984. It is a provider of inpatient rehabilitative health care services in the United States. The Company's inpatient rehabilitation hospitals offer specialized rehabilitative care to diagnose and patient care services. Patient care is provided by nursing and therapy staff as directed by a physician order. As of December 31, 2013, it operated 103 inpatient rehabilitation hospitals including 2 hospitals that operate as joint ventures which it account for using the equity method of accounting, 20 outpatient rehabilitation satellite clinics operated by its hospitals and 25 licensed, hospital-based home health agencies. In addition to HealthSouth hospitals, it manages three inpatient rehabilitation units through management contracts. While it's national network of inpatient hospitals in 28 states and Puerto Rico, its inpatient hospitals are located in the eastern half of the United States and Texas. The Company's inpatient rehabilitation hospitals compete with rehabilitation units, many of which are within acute care hospitals, and skilled nursing facilities in the market. It treats patients of all ages. Its patients are persons aged 65 years and older. The Company is subject to significant federal, state, and local regulation.
» More Articles for HSRPP

Headlines

Articles On GuruFocus.com
Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 
26.25% Annual Return With Lobbying Stocks? Here Is How It Works Nov 21 2014 
5 Stocks Building Long-Term Wealth With Increased Dividends Jul 28 2014 
"Thrift, fearlessness, resilience, hard work" - What Makes Mariko Gordon Our Newest Guru Dec 07 2013 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
physical therepy Jan 09 2013 
physical therepy Jan 09 2013 
HEALTHSOUTH Corp. Reports Operating Results (10-K) Feb 24 2011 
HealthSouth Reports Results for Second Quarter 2009 and Increases 2009 Guidance Aug 04 2009 
HealthSouth Declares Dividend on 6.5 Percent Series A Convertible Perpetual Preferred Stock Dec 18 2008 

More From Other Websites
Affordable Care Act Ruling Expected to Intensify Health Care M&A Jun 26 2015
Is HEALTHSOUTH (HLS) Stock a Solid Choice Right Now? - Tale of the Tape Jun 19 2015
Birmingham's best and worst performing stocks in 2015 Jun 17 2015
A Westerville hospital will create 100 jobs when it opens in 2017 Jun 17 2015
HEALTHSOUTH (HLS) Worth Watching: Stock Rises 9.5% - Tale of the Tape Jun 12 2015
HealthSouth Hospital Buyout To Boost Earnings Jun 11 2015
HealthSouth to buy rehab hospital operator for $730 mln Jun 11 2015
HealthSouth to buy in patient rehab hospital operator for $730 million Jun 11 2015
Edited Transcript of HLS corporate analyst meeting Jun 11 2015
Wedbush Initiates On A Ton Of Healthcare Stocks Jun 10 2015
Healthsouth 8-K Shows FY 2015 EPS $2.13-$2.19 Jun 09 2015
10-Q for HealthSouth Corp. May 03 2015
HealthSouth Profit Falls 9% on Bad Debt Provision Apr 30 2015
HealthSouth misses 1Q profit forecasts Apr 30 2015
HealthSouth misses 1Q profit forecasts Apr 30 2015
Medicare's (Stay) Home Savings Plan Apr 17 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK